Published in Diabetes Care on November 01, 2009
Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal Study. Circulation (2011) 2.13
Obesity paradox does exist. Diabetes Care (2013) 1.40
The downside of weight loss: realistic intervention in body-weight trajectory. Can Fam Physician (2012) 1.11
An overview of the contribution of fatness and fitness factors, and the role of exercise, in the formation of health status for individuals who are overweight. J Diabetes Metab Disord (2012) 0.84
Joint effects of physical activity and BMI on risk of hypertension in women: a longitudinal study. J Obes (2014) 0.81
Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia. Biol Res Nurs (2010) 0.80
Criterion validity and reliability of a smartphone delivered sub-maximal fitness test for people with type 2 diabetes. BMC Sports Sci Med Rehabil (2016) 0.78
Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus. Schizophr Bull (2015) 0.78
Evolution of lipid management guidelines: evidence might set you free. Can Fam Physician (2014) 0.75
[Obesity and type 2 diabetes]. Wien Klin Wochenschr (2016) 0.75
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA (1995) 38.40
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA (1989) 14.34
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med (1986) 11.17
Body weight and mortality among women. N Engl J Med (1995) 11.04
Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63
Breaks in sedentary time: beneficial associations with metabolic risk. Diabetes Care (2008) 8.04
The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med (1993) 7.69
Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA (1996) 7.45
Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med (1992) 7.45
Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. JAMA (1995) 7.14
Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36
Physical fitness in childhood and adolescence: a powerful marker of health. Int J Obes (Lond) (2007) 4.07
Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med (2000) 3.66
Features of the metabolic syndrome are associated with objectively measured physical activity and fitness in Danish children: the European Youth Heart Study (EYHS). Diabetes Care (2004) 3.15
Associations of light, moderate, and vigorous intensity physical activity with longevity. The Harvard Alumni Health Study. Am J Epidemiol (2000) 3.05
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA (2006) 2.99
Familial aggregation of VO(2max) response to exercise training: results from the HERITAGE Family Study. J Appl Physiol (1985) (1999) 2.89
Physical activity recommendations and decreased risk of mortality. Arch Intern Med (2007) 2.76
Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J (2002) 2.46
Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. Am J Epidemiol (2002) 2.35
Body weight: implications for the prevention of coronary heart disease, stroke, and diabetes mellitus in a cohort study of middle aged men. BMJ (1997) 2.33
Physical activity energy expenditure predicts progression toward the metabolic syndrome independently of aerobic fitness in middle-aged healthy Caucasians: the Medical Research Council Ely Study. Diabetes Care (2005) 2.23
Prescribing exercise at varied levels of intensity and frequency: a randomized trial. Arch Intern Med (2005) 2.12
Fatness is a better predictor of cardiovascular disease risk factor profile than aerobic fitness in healthy men. Circulation (2005) 2.01
Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth. J Appl Physiol (1985) (2008) 1.78
Physical activity, sedentary behavior, and the risk of colon and rectal cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control (2008) 1.76
Cardiorespiratory fitness and the incidence of type 2 diabetes: prospective study of Japanese men. Diabetes Care (2003) 1.72
Assessment of excess mortality in obesity. Am J Epidemiol (1998) 1.62
Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring) (2009) 1.60
Cardiorespiratory fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in men. Diabetes Care (2005) 1.58
Genetics of aerobic and anaerobic performances. Exerc Sport Sci Rev (1992) 1.55
The influence of physical activity on abdominal fat: a systematic review of the literature. Obes Rev (2006) 1.41
Response to physical activity programs and their effects on health behavior. Public Health Rep (1970) 1.41
Overall obesity and abdominal adiposity as predictors of mortality in u.s. White and black adults. Ann Epidemiol (2009) 1.29
Markers of inflammation are inversely associated with VO2 max in asymptomatic men. J Appl Physiol (1985) (2006) 1.16
US weight guidelines: is it also important to consider cardiorespiratory fitness? Int J Obes Relat Metab Disord (1998) 1.11
Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men. Am J Clin Nutr (2008) 1.10
The effect of cardiorespiratory fitness and obesity on cancer mortality in women and men. Med Sci Sports Exerc (2003) 1.07
Cardiorespiratory fitness as a feature of metabolic syndrome in older men and women: the Dose-Responses to Exercise Training study (DR's EXTRA). Diabetes Care (2008) 1.05
Familial aggregation of submaximal aerobic performance in the HERITAGE Family study. Med Sci Sports Exerc (2001) 1.04
Associations of low-grade inflammation with physical activity, fitness and fatness in prepubertal children; the European Youth Heart Study. Int J Obes (Lond) (2007) 1.01
Cardiovascular fitness modifies the associations between physical activity and abdominal adiposity in children and adolescents: the European Youth Heart Study. Br J Sports Med (2008) 0.97
Cardiorespiratory fitness, different measures of adiposity, and cancer mortality in men. Obesity (Silver Spring) (2007) 0.95
The association between cardiorespiratory fitness and prostate cancer. Med Sci Sports Exerc (1996) 0.92
Habitual physical activity and bone mineral density in postmenopausal women in England. Int J Epidemiol (1999) 0.92
Cardiorespiratory fitness as a predictor of cancer mortality among men with pre-diabetes and diabetes. Diabetes Care (2007) 0.89
Management of obesity in adults: European clinical practice guidelines. Obes Facts (2008) 1.59
Treatment modalities of obesity: what fits whom? Diabetes Care (2008) 1.58
Intralesional lipolysis with phosphatidylcholine for the treatment of lipomas: pilot study. Arch Dermatol (2006) 1.47
A pilot study of mobile phone-based therapy for obese patients. J Telemed Telecare (2008) 1.24
Evaluation of a new DNA test compared with the lactose hydrogen breath test for the diagnosis of lactase non-persistence. Eur J Gastroenterol Hepatol (2005) 1.14
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism (2013) 1.04
Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts (2013) 1.04
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care (2013) 1.03
Weight loss improves the adipogenic capacity of human preadipocytes and modulates their secretory profile. Diabetes (2013) 0.90
European Guidelines for Obesity Management in Adults. Obes Facts (2015) 0.88
Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group). Neuropsychiatr Dis Treat (2009) 0.85
An EASO position statement on multidisciplinary obesity management in adults. Obes Facts (2014) 0.82
Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and early vascular ageing. J Hypertens (2015) 0.82
[Antihyperglycemic Treatment Guidelines for diabetes mellitus type 2]. Wien Klin Wochenschr (2012) 0.79
[Mental disorders and diabetes mellitus]. Wien Klin Wochenschr (2012) 0.79
Criteria for EASO-collaborating centres for obesity management. Obes Facts (2011) 0.78
Ursodeoxycholic acid but not tauroursodeoxycholic acid inhibits proliferation and differentiation of human subcutaneous adipocytes. PLoS One (2013) 0.78
Need for a paradigm shift in adult overweight and obesity management - an EASO position statement on a pressing public health, clinical and scientific challenge in Europe. Obes Facts (2014) 0.78
Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications. Clin Exp Hypertens (2014) 0.78
Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group). Neuropsychiatr Dis Treat (2012) 0.76
[The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus]. Wien Klin Wochenschr (2009) 0.76
[Lipids: diagnosis and therapy in type 2 diabetes]. Wien Klin Wochenschr (2012) 0.76
Clinical-pathological conference series from the Medical University of Graz : case no. 131: elevated transaminases in a 30-year-old male. Wien Klin Wochenschr (2006) 0.76
Effects of orlistat therapy on plasma concentrations of oxygenated and hydrocarbon carotenoids. Lipids (2006) 0.75
New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Wien Klin Wochenschr (2014) 0.75
Are there differences in LDL-C target value attainment in Austrian federal states? Yes! Wien Med Wochenschr (2013) 0.75
A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk. Obes Facts (2017) 0.75
2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO. Obes Facts (2016) 0.75
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure. J Hypertens (2016) 0.75
Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management. Obes Facts (2017) 0.75
Impact of depression on diabetes mellitus. Obes Facts (2009) 0.75
Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way. Obes Facts (2017) 0.75
Histopathologic changes after intralesional application of phosphatidylcholine for lipoma reduction: report of a case. Am J Dermatopathol (2006) 0.75
Comment on the Paper by Uerlich et al: Obesity Management in Europe: Current Status and Objectives for the Future. Obes Facts 2016;9:273-283. Obes Facts (2016) 0.75